Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Oldfield

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Journal of Medicinal Chemistry|April 15, 2005
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorptionJohn M Sanders, Yongcheng Song, Julian M W Chan, et al.
Journal of the American Chemical Society|March 25, 2009
Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigationYonghui Zhang, Rong Cao, Fenglin Yin, et al.
ACS Infectious Diseases|August 14, 2024
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against <i>Plasmodium falciparum</i>Savannah J Watson, Mariëtte E van der Watt, Anjo Theron, et al.
Plos Pathogens|May 3, 2014
Squalene synthase as a target for Chagas disease therapeuticsNa Shang, Qian Li, Tzu-Ping Ko, et al.
Journal of Medicinal Chemistry|February 27, 2014
Multitarget drug discovery for tuberculosis and other infectious diseasesKai Li, Lici A Schurig-Briccio, Xinxin Feng, et al.
Nature|September 6, 2023
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cellsLinjie Yuan, Xianqiang Ma, Yunyun Yang, et al.
Nature Chemical Biology|August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomesJeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Journal of Medicinal Chemistry|April 15, 2005
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorptionJohn M Sanders, Yongcheng Song, Julian M W Chan, et al.
Journal of the American Chemical Society|March 25, 2009
Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigationYonghui Zhang, Rong Cao, Fenglin Yin, et al.
ACS Infectious Diseases|August 14, 2024
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against <i>Plasmodium falciparum</i>Savannah J Watson, Mariëtte E van der Watt, Anjo Theron, et al.
Plos Pathogens|May 3, 2014
Squalene synthase as a target for Chagas disease therapeuticsNa Shang, Qian Li, Tzu-Ping Ko, et al.
Journal of Medicinal Chemistry|February 27, 2014
Multitarget drug discovery for tuberculosis and other infectious diseasesKai Li, Lici A Schurig-Briccio, Xinxin Feng, et al.
Nature|September 6, 2023
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cellsLinjie Yuan, Xianqiang Ma, Yunyun Yang, et al.
Nature Chemical Biology|August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomesJeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against <i>Mycobacterium abscessus</i> and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Pageof 20